Drug Type Small molecule drug |
Synonyms Elinafide, LU 79553, LU-79553 |
Target |
Mechanism DNA intercalators, Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC33H36N4O10S2 |
InChIKeyZDEINNOMAWXNKF-UHFFFAOYSA-N |
CAS Registry199330-45-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 2 | - | - | |
Mesothelioma | Phase 2 | - | - | |
Neoplasms | Phase 2 | US | - | |
Neoplasms | Phase 2 | DE | - | |
Ovarian Cancer | Phase 2 | - | - |